(Q34426702)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

review article

1 reference

title

Salvage radiotherapy for PSA failure after radical prostatectomy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

adaptive radiation therapy

2 December 2019

main subject

0 references

author

Padraig Warde

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

C Parker

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

C Catton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy and Oncology

2 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

107-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Effect of Adjuvant Radiation Therapy on Prostate Specific Antigen Following Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Yield of imaging and scintigraphy assessing biochemical failure in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Serum prostate-specific antigen after post-prostatectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Use of endorectal MR imaging to predict prostate carcinoma recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

The management of PSA failure after radical radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Neutron beam radiotherapy for recurrent prostate cancer following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Needle biopsy of recurrent adenocarcinoma of the prostate after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900439-X

7 January 2021

10.1016/S0167-8140(01)00439-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11690675%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference